Rair Health Limited LONDON


Founded in 2016, Rair Health, classified under reg no. 10039808 is an active company. Currently registered at 20 Dents Road SW11 6JA, London the company has been in the business for eight years. Its financial year was closed on December 31 and its latest financial statement was filed on 2022/12/31. Since 2019/03/09 Rair Health Limited is no longer carrying the name Actu8 Immunotherapeutics.

Currently there are 3 directors in the the firm, namely Michael D., Gordon D. and Steven C.. In addition one secretary - Steven C. - is with the company. As of 27 April 2024, there was 1 ex director - Geoffrey C.. There were no ex secretaries.

Rair Health Limited Address / Contact

Office Address 20 Dents Road
Town London
Post code SW11 6JA
Country of origin United Kingdom

Company Information / Profile

Registration Number 10039808
Date of Incorporation Thu, 3rd Mar 2016
Industry Information technology consultancy activities
Industry Research and experimental development on biotechnology
End of financial Year 31st December
Company age 8 years old
Account next due date Mon, 30th Sep 2024 (156 days left)
Account last made up date Sat, 31st Dec 2022
Next confirmation statement due date Sat, 16th Mar 2024 (2024-03-16)
Last confirmation statement dated Thu, 2nd Mar 2023

Company staff

Michael D.

Position: Director

Appointed: 01 September 2020

Gordon D.

Position: Director

Appointed: 01 September 2020

Steven C.

Position: Director

Appointed: 03 March 2016

Steven C.

Position: Secretary

Appointed: 03 March 2016

Geoffrey C.

Position: Director

Appointed: 03 March 2016

Resigned: 20 April 2021

People with significant control

The register of PSCs who own or have control over the company is made up of 2 names. As we identified, there is Steven Howard C. The abovementioned PSC has 75,01-100% voting rights and has 75,01-100% shares. The second entity in the PSC register is Geoffrey C. This PSC owns 25-50% shares.

Steven Howard C.

Notified on 6 April 2016
Nature of control: 75,01-100% shares
75,01-100% voting rights

Geoffrey C.

Notified on 6 April 2016
Ceased on 2 October 2020
Nature of control: 25-50% shares

Company previous names

Actu8 Immunotherapeutics March 9, 2019

Annual reports financial information

Profit & Loss
Accounts Information Date 2017-03-312018-03-312019-03-312020-03-312020-12-312021-12-312022-12-31
Net Worth100      
Balance Sheet
Cash Bank On Hand10354922527 54924 2399 397
Current Assets1092495 27330 47436 97621 217
Debtors   5 0482 92512 73711 820
Net Assets Liabilities100133176-27 552-41 416-157 592-263 447
Other Debtors   5 0482 92512 19111 820
Net Assets Liabilities Including Pension Asset Liability100      
Reserves/Capital
Shareholder Funds100      
Other
Accrued Liabilities    1 440100 954192 079
Accumulated Amortisation Impairment Intangible Assets   2 395   
Average Number Employees During Period   4433
Convertible Debt Securities Held   29 00059 37789 37789 377
Creditors 22522532 91571 890194 568284 664
Fixed Assets901 0422 48590   
Increase From Amortisation Charge For Year Intangible Assets   2 395   
Intangible Assets  2 395    
Intangible Assets Gross Cost  2 3952 395   
Investments Fixed Assets904409090   
Investments In Subsidiaries  9090-90  
Net Current Assets Liabilities10133176-27 642-41 416  
Number Shares Issued Fully Paid  1001 3801 3801 3801 380
Other Creditors  2 7102 9607 9602 9602 960
Par Value Share   1111
Prepayments     546 
Total Assets Less Current Liabilities1009092 309    
Total Borrowings   29 00059 37789 37789 377
Trade Creditors Trade Payables   9553 1131 277248

Company filings

Filing category
Accounts Capital Confirmation statement Incorporation Officers Persons with significant control Resolution
Total exemption full accounts record for the accounting period up to 2022/12/31
filed on: 29th, September 2023
Free Download (9 pages)

Company search

Advertisements